Design of novel chimeras provides insight into structure/function activity of apolipoprotein E3 and apolipoprotein AI
<p> Apolipoprotein (apo) E3 (299 residues, ∼34 kDa) and apoAI (243 residues, ∼28 kDa) are exchangeable apolipoproteins that play a dominant role in regulating plasma cholesterol levels and are considered anti-atherogenic. The N-terminal (NT) domain of apoE3 mediates cellular up...
Main Author: | Lek, Mark T. |
---|---|
Language: | EN |
Published: |
California State University, Long Beach
2017
|
Subjects: | |
Online Access: | http://pqdtopen.proquest.com/#viewpdf?dispub=10196288 |
Similar Items
-
Antimicrobial and lipid binding properties of the C-terminal domain of apolipoprotein A-I determined using a novel apolipophorin III/apolipoprotein A-I (179-243) chimera
by: Rachel A. Ellena
Published: (2016) -
Structural and Functional Analysis of Apolipoprotein E3/E4 Hybrid
by: Tu, Kai-Han
Published: (2017) -
Structure, function and atherogenicity of apolipoprotein B containing lipoproteins
by: Anber, Vian
Published: (1997) -
Expression and structure-function relationship of human apolipoprotein (APO) C111
by: Liu, Hai-Qun
Published: (2001) -
Structure-Function Studies of Apolipoprotein A5: a Regulator of Plasma Triglycerides
by: Castleberry, Mark A.
Published: (2020)